{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:55:58Z","timestamp":1766159758944,"version":"3.48.0"},"reference-count":102,"publisher":"Edizioni Minerva Medica","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Angiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.23736\/s0392-9590.25.05462-8","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:28:03Z","timestamp":1764599283000},"source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of micronized purified flavonoid fraction on venous symptoms and signs in patients at all stages of chronic venous disease: a systematic review and meta-analysis. Part I: symptoms"],"prefix":"10.23736","volume":"44","author":[{"given":"Andrew","family":"NICOLAIDES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirill","family":"LOBASTOV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"MANSILHA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro J.","family":"GONZALEZ-OCHOA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"BLANC-GUILLEMAUD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Blanche","family":"ONSELAER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumeya","family":"SERIFOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hurrem P.","family":"YALTIRIK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayanan","family":"SRIRAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianrui","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"KAKKOS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17149","reference":[{"key":"10.23736\/S0392-9590.25.05462-8_ref001","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000004631"},{"key":"10.23736\/S0392-9590.25.05462-8_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2004.09.027"},{"key":"10.23736\/S0392-9590.25.05462-8_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2019.12.075"},{"key":"10.23736\/S0392-9590.25.05462-8_ref004","first-page":"374","article-title":"Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum","volume":"35","author":"Perrin M","year":"2016","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref005","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2000.110509"},{"key":"10.23736\/S0392-9590.25.05462-8_ref006","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.12.1420"},{"key":"10.23736\/S0392-9590.25.05462-8_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2015.05.013"},{"key":"10.23736\/S0392-9590.25.05462-8_ref008","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-0882-6"},{"key":"10.23736\/S0392-9590.25.05462-8_ref009","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2014.09.008"},{"key":"10.23736\/S0392-9590.25.05462-8_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2009.11.014"},{"key":"10.23736\/S0392-9590.25.05462-8_ref011","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab495"},{"key":"10.23736\/S0392-9590.25.05462-8_ref012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2021.08.021"},{"key":"10.23736\/S0392-9590.25.05462-8_ref013","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab589"},{"key":"10.23736\/S0392-9590.25.05462-8_ref014","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.18.03999-8"},{"key":"10.23736\/S0392-9590.25.05462-8_ref015","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.20.04388-6"},{"key":"10.23736\/S0392-9590.25.05462-8_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2021.12.024"},{"key":"10.23736\/S0392-9590.25.05462-8_ref017","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-023-01261-y"},{"key":"10.23736\/S0392-9590.25.05462-8_ref018","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.18.03975-5"},{"key":"10.23736\/S0392-9590.25.05462-8_ref019","first-page":"CD003229","article-title":"Phlebotonics for venous insufficiency","volume":"11","author":"Martinez-Zapata MJ","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.23736\/S0392-9590.25.05462-8_ref020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.23736\/S0392-9590.25.05462-8","article-title":"Effectiveness of micronized purified flavonoid fraction on venous symptoms and signs in patients at all stages of chronic venous disease: A systematic review and meta-analysis. Part II: signs","volume":"44","author":"Nicolaides A","year":"2025","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref021","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"10.23736\/S0392-9590.25.05462-8_ref022","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"10.23736\/S0392-9590.25.05462-8_ref023","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"10.23736\/S0392-9590.25.05462-8_ref024","unstructured":"Higgins JP, Li T, Deeks JJ. Choosing effect measures and computing estimates of effect. In: Higgins JPT, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 Chapter 6: The standardized mean difference; 6.5.1.2."},{"key":"10.23736\/S0392-9590.25.05462-8_ref025","doi-asserted-by":"publisher","DOI":"10.1177\/0013164403256358"},{"key":"10.23736\/S0392-9590.25.05462-8_ref026","unstructured":"Higgins JP, Li T, Deeks JJ. Choosing effect measures and computing estimates of effect. In: Higgins JPT, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Chapter 6. Imputing standard deviations for changes from baseline; 6.5.2.8."},{"key":"10.23736\/S0392-9590.25.05462-8_ref027","unstructured":"Higgins JP, Li T, Deeks JJ. Choosing effect measures and computing estimates of effect. In: Higgins JPT, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Chapter 6: Obtaining standard deviations from standard errors, confidence intervals, t statistics and P values for differences in means; 6.5.2.3."},{"key":"10.23736\/S0392-9590.25.05462-8_ref028","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.11.003"},{"key":"10.23736\/S0392-9590.25.05462-8_ref029","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"10.23736\/S0392-9590.25.05462-8_ref030","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"10.23736\/S0392-9590.25.05462-8_ref031","first-page":"40","article-title":"meta: an R package for meta-analysis","volume":"7","author":"Schwarzer G","year":"2007","journal-title":"R News"},{"key":"10.23736\/S0392-9590.25.05462-8_ref032","first-page":"95","article-title":"Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg","volume":"80","author":"Tsouderos Y","year":"1991","journal-title":"Z Kardiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref033","first-page":"80","article-title":"Chemotherapy of chronic venous insufficiency: experience of using Detralex","volume":"68","author":"Yablogov EG","year":"1996","journal-title":"Ter Arkh"},{"key":"10.23736\/S0392-9590.25.05462-8_ref034","first-page":"32","article-title":"Activit\u00e9 th\u00e9rapeutique de Daflon 500 mg dans l'insuffisance veineuse fonctionnelle","author":"Chassignolle JF","year":"1987","journal-title":"J Intern Med"},{"key":"10.23736\/S0392-9590.25.05462-8_ref035","first-page":"69","article-title":"A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility","volume":"12","author":"Galley P","year":"1993","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref036","doi-asserted-by":"publisher","DOI":"10.1177\/026835559400900206"},{"key":"10.23736\/S0392-9590.25.05462-8_ref037","first-page":"39","article-title":"Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg","volume":"7","author":"Laurent R","year":"1988","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref038","first-page":"1","article-title":"Venous Insufficiency and Daflon 500 mg","volume":"9","author":"Planchon B","year":"1990","journal-title":"Arteres Veines"},{"key":"10.23736\/S0392-9590.25.05462-8_ref039","first-page":"181","article-title":"Can Micronized Purified Flavonoid Fraction (MPFF) improve outcomes of lower extremity varicose vein endovenous treatment? First results from the DECISION study","volume":"20","author":"Bogachev VY","year":"2013","journal-title":"Phlebolymphology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref040","doi-asserted-by":"publisher","DOI":"10.1159\/000179095"},{"key":"10.23736\/S0392-9590.25.05462-8_ref041","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(96)80081-6"},{"key":"10.23736\/S0392-9590.25.05462-8_ref042","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.17.03801-9"},{"key":"10.23736\/S0392-9590.25.05462-8_ref043","first-page":"399","article-title":"Clinical acceptability study of once-daily versus twice-daily micronized purified flavonoid fraction in patients with symptomatic chronic venous disease: a randomized controlled trial","volume":"35","author":"Kirienko A","year":"2016","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref044","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.22.04987-2"},{"key":"10.23736\/S0392-9590.25.05462-8_ref045","doi-asserted-by":"publisher","DOI":"10.1177\/0268355594009001s06"},{"key":"10.23736\/S0392-9590.25.05462-8_ref046","doi-asserted-by":"publisher","DOI":"10.1177\/107602960601200209"},{"key":"10.23736\/S0392-9590.25.05462-8_ref047","first-page":"61","article-title":"Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form","volume":"8","author":"Cospite M","year":"1989","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref048","first-page":"381","article-title":"Efficacy and safety of trombless\u00ae Neo and Detralex\u00ae in the treatment of chronic venous diseases are the results of an open-label, comparative, multicenter randomized prospective study","volume":"11","author":"Gildeeva GN","year":"2020","journal-title":"Syst Rev Pharm"},{"key":"10.23736\/S0392-9590.25.05462-8_ref049","first-page":"428","article-title":"Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial","volume":"34","author":"Rabe E","year":"2015","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref050","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4237204"},{"key":"10.23736\/S0392-9590.25.05462-8_ref051","first-page":"657","article-title":"Calcium dobesilate versus micronised purified flavonoid fraction of diosmin in the treatment of chronic venous disease: a randomized prospective study","volume":"34","author":"Yalvac ES","year":"2018","journal-title":"Acta Med Mediter"},{"key":"10.23736\/S0392-9590.25.05462-8_ref052","first-page":"257","article-title":"Electrical muscle stimulation with Veinoplus\u00ae device in the treatment of venous ulcers","volume":"34","author":"Bogachev VY","year":"2015","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref053","doi-asserted-by":"publisher","DOI":"10.1177\/026835559901400405"},{"key":"10.23736\/S0392-9590.25.05462-8_ref054","first-page":"24","article-title":"Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency","volume":"22","author":"Roztocil K","year":"2003","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref055","first-page":"47","article-title":"Analysis report of an open, randomised, multicentre comparative study of efficiency and safety of Detralex in complementary treatment of complications of chronic venous insufficiency of lower extremities (trophic ulcers)","volume":"8","author":"Saveljev VP","year":"2002","journal-title":"Angiology and Vascular Surgery"},{"key":"10.23736\/S0392-9590.25.05462-8_ref056","doi-asserted-by":"publisher","DOI":"10.5455\/annalsmedres.2020.06.624"},{"key":"10.23736\/S0392-9590.25.05462-8_ref057","first-page":"37","article-title":"Quantification of oedema using the volometer technique: therapeutic application of Daflon 500 mg in chronic venous insufficiency","author":"Blume J","year":"1992","journal-title":"Phlebology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref058","first-page":"30","article-title":"Study of the efficacy of Daflon 500 MG in 1931 patients with chronic venous insufficiency","volume":"39","author":"Elbaz C","year":"1989","journal-title":"Gazette M\u00e9dicale"},{"key":"10.23736\/S0392-9590.25.05462-8_ref059","doi-asserted-by":"publisher","DOI":"10.1177\/153857440003400112"},{"key":"10.23736\/S0392-9590.25.05462-8_ref060","first-page":"67","article-title":"A long term treatment with a venotropic drug. Results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency","volume":"8","author":"Guillot B","year":"1989","journal-title":"Int Angiol"},{"key":"10.23736\/S0392-9590.25.05462-8_ref061","first-page":"85","article-title":"Study of the efficacy and acceptability of Daflon 500 mg in 1779 patients with venous insufficiency","volume":"96","author":"Henriet JP","year":"1989","journal-title":"Gazette M\u00e9dicale"},{"key":"10.23736\/S0392-9590.25.05462-8_ref062","first-page":"137","article-title":"Efficacy of a 6 month treatment with Detralex in patients with venous edema","volume":"17","author":"Navratilova Z","year":"2010","journal-title":"Phlebology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref063","first-page":"63","article-title":"The therapeutic activity of Daflon 500 mg in 320 cases of chronic venous insufficiency of the lower limbs","volume":"95","author":"Peker CL","year":"1988","journal-title":"Gazette M\u00e9dicale"},{"key":"10.23736\/S0392-9590.25.05462-8_ref064","first-page":"182","article-title":"Benefit of Daflon 500 mg in combination with sclerotherapy of telangiectasias of the lower limbs: results from the SYNERGY and SATISFY surveys","volume":"19","author":"Pitsch F","year":"2011","journal-title":"Phlebolymphology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref065","first-page":"41","article-title":"Therapeutic efficacy of Daflon 500 MG* in the treatment of chronic venous insufficiency in more than 11000 patients","volume":"337","author":"Roux E","year":"1990","journal-title":"Tribune Medicale"},{"key":"10.23736\/S0392-9590.25.05462-8_ref066","doi-asserted-by":"publisher","DOI":"10.1177\/153857440103500604"},{"key":"10.23736\/S0392-9590.25.05462-8_ref067","first-page":"18","article-title":"Great sphenous vein transitory reflux in patients with symptoms related to chronic venous disorders, but without visible signs (C0s), and its correction with MPFF treatment","volume":"22","author":"Tsoukanov YT","year":"2015","journal-title":"Phlebolymphology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref068","first-page":"110","article-title":"[Transitory (evening) venous reflux in patients with intracutaneous varicosity and medicamentous correction thereof]","volume":"22","author":"Tsukanov YT","year":"2016","journal-title":"Angiol Sosud Khir"},{"key":"10.23736\/S0392-9590.25.05462-8_ref069","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.16.03708-1"},{"key":"10.23736\/S0392-9590.25.05462-8_ref070","first-page":"146","article-title":"Neby litsy YS, Nazaruk AM. Benefits of MPFF on primary chronic venous disease related symptoms and quality of life: the DELTA study","volume":"21","author":"Yanushko AV","year":"2014","journal-title":"Phlebolymphology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref071","first-page":"90","article-title":"[Ultrasound elastography in assessing efficacy of treatment for lower limb varicose veins with a phlebotrophic drug containing a micronized purified flavonoid fraction]","volume":"20","author":"Zubarev AR","year":"2014","journal-title":"Angiol Sosud Khir"},{"key":"10.23736\/S0392-9590.25.05462-8_ref072","doi-asserted-by":"publisher","DOI":"10.2217\/fca-2022-0026"},{"key":"10.23736\/S0392-9590.25.05462-8_ref073","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-019-00637-5"},{"key":"10.23736\/S0392-9590.25.05462-8_ref074","first-page":"79","article-title":"Benefit of Daflon 500 mg in the reduction of chronic venous disease-related symptoms","volume":"19","author":"Lenkovic M","year":"2012","journal-title":"Phlebolymphology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref075","first-page":"44","article-title":"Patients seeking treatment for chronic venous disorders-Russian results from the VEIN Act program","volume":"23","author":"Lishov DE","year":"2016","journal-title":"Phlebolymphology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref076","doi-asserted-by":"publisher","DOI":"10.1258\/0268355042555028"},{"key":"10.23736\/S0392-9590.25.05462-8_ref077","doi-asserted-by":"publisher","DOI":"10.1177\/02683555211002331"},{"key":"10.23736\/S0392-9590.25.05462-8_ref078","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-021-00249-4"},{"key":"10.23736\/S0392-9590.25.05462-8_ref079","first-page":"45","article-title":"Stripping of the great saphenous vein under micronized purified flavonoid fraction (MPFF) protection (results of the Russian multicenter controlled trial DEFANCE)","volume":"15","author":"Saveljev VS","year":"2008","journal-title":"Phlebolymphology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref080","doi-asserted-by":"publisher","DOI":"10.1177\/000331979304400109"},{"key":"10.23736\/S0392-9590.25.05462-8_ref081","first-page":"68","article-title":"[Risk factors of chronic venous insufficiency of the lower extremities and possibilities of its medication in therapeutic practice]","volume":"78","author":"Oganov RG","year":"2006","journal-title":"Ter Arkh"},{"key":"10.23736\/S0392-9590.25.05462-8_ref082","first-page":"144","article-title":"Diagnosis and treatment of situational great saphenous vein reflux in daily medical practice","volume":"24","author":"Tsukanov YT","year":"2017","journal-title":"Phlebolymphology"},{"key":"10.23736\/S0392-9590.25.05462-8_ref083","doi-asserted-by":"publisher","DOI":"10.1177\/000331970205300301"},{"key":"10.23736\/S0392-9590.25.05462-8_ref084","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0731-z"},{"key":"10.23736\/S0392-9590.25.05462-8_ref085","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.22.04877-5"},{"key":"10.23736\/S0392-9590.25.05462-8_ref086","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02643-6"},{"key":"10.23736\/S0392-9590.25.05462-8_ref087","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(89)90005-6"},{"key":"10.23736\/S0392-9590.25.05462-8_ref088","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2018.05.007"},{"key":"10.23736\/S0392-9590.25.05462-8_ref089","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(18)31203-0"},{"key":"10.23736\/S0392-9590.25.05462-8_ref090","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2014.12.031"},{"key":"10.23736\/S0392-9590.25.05462-8_ref091","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.19.04216-0"},{"key":"10.23736\/S0392-9590.25.05462-8_ref092","doi-asserted-by":"publisher","DOI":"10.1177\/0268355513515859"},{"key":"10.23736\/S0392-9590.25.05462-8_ref093","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2008.09.014"},{"key":"10.23736\/S0392-9590.25.05462-8_ref094","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2007.08.048"},{"key":"10.23736\/S0392-9590.25.05462-8_ref095","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2007.08.038"},{"key":"10.23736\/S0392-9590.25.05462-8_ref096","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02218-x"},{"key":"10.23736\/S0392-9590.25.05462-8_ref097","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-023-01263-w"},{"key":"10.23736\/S0392-9590.25.05462-8_ref098","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1278374"},{"key":"10.23736\/S0392-9590.25.05462-8_ref099","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmv.2006.10.001"},{"key":"10.23736\/S0392-9590.25.05462-8_ref100","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-9590.17.03868-8"},{"key":"10.23736\/S0392-9590.25.05462-8_ref101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1549-8719.2000.tb00741.x"},{"key":"10.23736\/S0392-9590.25.05462-8_ref102","doi-asserted-by":"publisher","DOI":"10.1177\/0268355516689631"}],"container-title":["International Angiology"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R34Y2025N06A0445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:25:50Z","timestamp":1766150750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R34Y2025N06A0445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":102,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.23736\/s0392-9590.25.05462-8","relation":{},"ISSN":["0392-9590","1827-1839"],"issn-type":[{"type":"print","value":"0392-9590"},{"type":"electronic","value":"1827-1839"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}